G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 95 filers reported holding G1 THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $236,000 | -55.2% | 20,495 | -5.8% | 0.00% | -100.0% |
| Q2 2020 | $527,000 | +34.8% | 21,754 | -38.7% | 0.00% | 0.0% |
| Q1 2020 | $391,000 | -71.2% | 35,494 | -30.8% | 0.00% | 0.0% |
| Q4 2019 | $1,356,000 | -19.5% | 51,303 | -24.6% | 0.00% | -50.0% |
| Q3 2019 | $1,684,000 | +9.3% | 68,013 | +35.3% | 0.00% | +100.0% |
| Q2 2019 | $1,541,000 | +162.1% | 50,272 | +42.0% | 0.00% | 0.0% |
| Q1 2019 | $588,000 | +130.6% | 35,406 | +165.8% | 0.00% | – |
| Q4 2018 | $255,000 | – | 13,323 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 719,985 | $31,291,000 | 2.32% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 72,000 | $3,121,000 | 1.20% |
| EMERALD ADVISERS, LLC | 506,424 | $22,009,000 | 0.83% |
| Virtus ETF Advisers LLC | 18,103 | $787,000 | 0.70% |
| Birchview Capital, LP | 22,000 | $956,000 | 0.65% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 352,053 | $15,300,000 | 0.55% |
| Hillhouse Capital Management | 699,431 | $30,397,000 | 0.52% |
| Rock Springs Capital Management LP | 300,000 | $13,038,000 | 0.50% |
| BB BIOTECH AG | 352,607 | $15,324,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 287,000 | $12,473,000 | 0.44% |